These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16317474)

  • 21. [From teprotide to captopril. Rational design of ACE inhibitors].
    Nemec K; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2003; 32(1):11-6. PubMed ID: 12577755
    [No Abstract]   [Full Text] [Related]  

  • 22. Yak milk casein as a functional ingredient: preparation and identification of angiotensin-I-converting enzyme inhibitory peptides.
    Jiang J; Chen S; Ren F; Luo Z; Zeng SS
    J Dairy Res; 2007 Feb; 74(1):18-25. PubMed ID: 16987434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of angiotensin I converting enzyme inhibitory peptides from the rotifer, Brachionus rotundiformis.
    Lee JK; Hong S; Jeon JK; Kim SK; Byun HG
    Bioresour Technol; 2009 Nov; 100(21):5255-9. PubMed ID: 19540110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of domain-selective angiotensin I-converting enzyme inhibitors.
    Redelinghuys P; Nchinda AT; Sturrock ED
    Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glycosides and amino acyl esters of carbohydrates as potent inhibitors of angiotensin converting enzyme.
    Lohith K; Vijayakumar GR; Somashekar BR; Sivakumar R; Divakar S
    Eur J Med Chem; 2006 Sep; 41(9):1059-72. PubMed ID: 16730392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors.
    Gomez C; Berteina-Raboin S; De Nanteuil G; Guillaumet G
    Bioorg Med Chem; 2013 Nov; 21(22):7216-21. PubMed ID: 24095015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of human ACE gives new insights into inhibitor binding and design.
    Brew K
    Trends Pharmacol Sci; 2003 Aug; 24(8):391-4. PubMed ID: 12915047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An angiotensin-I converting enzyme inhibitor from buckwheat (Fagopyrum esculentum Moench) flour.
    Aoyagi Y
    Phytochemistry; 2006 Mar; 67(6):618-21. PubMed ID: 16458941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
    Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM
    J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides derived from porcine hemoglobin.
    Yu Y; Hu J; Miyaguchi Y; Bai X; Du Y; Lin B
    Peptides; 2006 Nov; 27(11):2950-6. PubMed ID: 16875758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the molecular recognition between bioactive peptides and angiotensin-converting enzyme.
    Pina AS; Roque AC
    J Mol Recognit; 2009; 22(2):162-8. PubMed ID: 18816584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.
    Mores A; Matziari M; Beau F; Cuniasse P; Yiotakis A; Dive V
    J Med Chem; 2008 Apr; 51(7):2216-26. PubMed ID: 18324760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The potential peptides against angiotensin-I converting enzyme through a virtual tripeptide-constructing library.
    Panyayai T; Sangsawad P; Pacharawongsakda E; Sawatdichaikul O; Tongsima S; Choowongkomon K
    Comput Biol Chem; 2018 Dec; 77():207-213. PubMed ID: 30347317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A heptameric peptide purified from Spirulina sp. gastrointestinal hydrolysate inhibits angiotensin I-converting enzyme- and angiotensin II-induced vascular dysfunction in human endothelial cells.
    Heo SY; Ko SC; Kim CS; Oh GW; Ryu B; Qian ZJ; Kim G; Park WS; Choi IW; Phan TT; Heo SJ; Kang DH; Yi M; Jung WK
    Int J Mol Med; 2017 May; 39(5):1072-1082. PubMed ID: 28393188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A variant peptide of buffalo colostrum β-lactoglobulin inhibits angiotensin I-converting enzyme activity.
    Rohit AC; Sathisha K; Aparna HS
    Eur J Med Chem; 2012 Jul; 53():211-9. PubMed ID: 22541393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA cleavage by copper-ATCUN complexes. Factors influencing cleavage mechanism and linearization of dsDNA.
    Jin Y; Cowan JA
    J Am Chem Soc; 2005 Jun; 127(23):8408-15. PubMed ID: 15941274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C domain-selective inhibition of angiotensin-converting enzyme.
    Ehlers MR; Abrie JA; Sturrock ED
    J Renin Angiotensin Aldosterone Syst; 2013 Jun; 14(2):189-92. PubMed ID: 23686914
    [No Abstract]   [Full Text] [Related]  

  • 39. Screening of ACE-inhibitory peptides from a random peptide-displayed phage library using ACE-coupled liposomes.
    Kumada Y; Hashimoto N; Hasan F; Terashima M; Nakanishi K; Jungbauer A; Katoh S
    J Biotechnol; 2007 Aug; 131(2):144-9. PubMed ID: 17658644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural features of angiotensin-I converting enzyme catalytic sites: conformational studies in solution, homology models and comparison with other zinc metallopeptidases.
    Spyroulias GA; Galanis AS; Pairas G; Manessi-Zoupa E; Cordopatis P
    Curr Top Med Chem; 2004; 4(4):403-29. PubMed ID: 14965309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.